{"schema_version":"secwatch.filing_event.v1","accession":"0001708599-24-000029","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2024-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.301533+00:00","generated_at":"2026-05-29T02:02:16.316357+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Serina shareholders approve equity plan amendment increasing share reserve by 950,000 shares","bullets":["Shareholders approved Amendment to 2024 Equity Incentive Plan, increasing shares reserved by 950,000 to 2,675,000.","Amendment also provides for automatic annual share increase of 5% of outstanding shares from FY2026 through FY2034.","Directors elected: Balkrishan 'Simba' Gill (5,998,349 votes), Remy Gross (5,963,359), Steven Mintz (5,953,931).","Ratification of Frazier & Deeter as independent auditors approved with 7,162,782 votes for, 90,321 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001708599-24-000029","json":"https://secwatch.observer/filing/0001708599-24-000029.json","markdown":"https://secwatch.observer/filing/0001708599-24-000029.md","text":"https://secwatch.observer/filing/0001708599-24-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000170859924000029/0001708599-24-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000170859924000029/ser-20241213.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T02:02:16.316357+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}